Policy | December 20, 2023
Norms for fixing prices of medicines
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Commenced operations in flood-affected Himachal Pradesh
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union
Medicines, including insulin, to be available in 40 lower-income countries
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
Subscribe To Our Newsletter & Stay Updated
